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Summary
Local anesthetics are not only used as drugs to block the sodium channel to
provide analgesia and anti-arrhythmic action. The purpose of this review is to
highlight the new indications and limitations of this class of drugs. Recent
research has focused on the use of i.v. local anesthetics to improve bowel
function after surgery or trauma, to protect the central nervous system, to find
new clues of local anesthetic effects in chronic neuropathic pain and to
investigate the long-term effect of anesthesia / analgesia provided by local
anesthetics on cancer recurrence. Recent facts dealing with myo- and chon-
drotoxicity are presented. There is growing evidence that local anesthetics
have a broad spectrum of indications aside analgesia and anti-arrhythmic
effect. Most of them are still insufficiently known and investigated. These new
indications will no doubt be intensively studied in the coming years.
INTRODUCTION
The use of local anesthetics has long been focused on the treatmentof pain and cardiac arrhythmias. During the last decades several
studies have demonstrated that local anesthetics are able to interfere
with other receptors (1). This has led to the administration of local
anesthetics in different settings including postoperative ileus, neuro-
protection, decompression sickness, cerebral air embolism, cancer re-
currence and various types of inflammation. On the other hand some
concerns including chondrotoxicity have been the focus of different
investigations. The aim of this review is to provide an overview of
recent progress in terms of new indications and limitations of local
anesthetic application.
Recovery of bowel function
Postsurgical ileus is a common occurrence after abdominal surgery,
and is one of the major reasons to delay patient’s discharge. Previous
studies have shown that continuous infusion of lidocaine has positive
effects in this setting (2, 3). These preliminary results have been confirmed
by Harvey et al (4). The authors examined in a prospective, randomized
and double-blinded study whether systemic infusion of lidocaine
(1 mg/min for 24h) compared to a placebo could reduce postoperative
pain, duration of postsurgical ileus and time to discharge. Patients
receiving lidocaine had less postoperative pain, the return of bowel
movement was fastened and they were discharged home one day earlier
than the others. Paralytic ileus is a major concern in the acute phase of
spinal cord injury. The effect of i.v. lidocaine infusion (2–3 mg/min)
was investigated in seven patients with severe traumatic spinal cord
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bowel function recovered 10–20 h after lidocaine initia-
tion5. Among the possible hypothesis to explain the salu-
tary effects of i.v. lidocaine, a reduction of the inflam-
matory reaction secondary to peritoneal distension and /
or reduction of post-traumatic – post-surgical stress have
been suggested (6, 7).
Beaussier et al (8). investigated the effects of parietal
analgesia on postoperative diaphragm dysfunction after
major open colorectal surgery. Patient received ropiva-
caine 0.2% given at a rate of 10ml/h during 48 h through
a preperitoneal wound catheter. PCA-morphine was us-
ed in the treatment and control group. Diaphragmatic
function was assessed by the sniff inspiratory pressure
test. It was shown that patients receiving preperitoneal
ropivacaine had a significant lower decrease in the sniff
inspiratory pressure compared to the control group at
24h – 24% vs – 58% and at 48h – 11% vs – 44%, respec-
tively. It was hypothesized that the beneficial effect could
be attributed not only to analgesia, but also to the blockade
of peritoneal afferents involved in the reflex diaphragma-
tic dysfunction induced by intra-abdominal surgery (9).
Neuroprotection / chronic pain
Several studies have previously shown that lidocaine
at antiarrhythmic doses (10) or lower doses (11) demon-
strates neuroprotective effects. These potential properties
are of great importance since the severity of neurologic
sequelae and the relatively limited therapeutic inter-
ventions make this an important area of research. Post-
operative neurocognitive decline is detected in more than
50% of patients after cardiac surgery and is still present 6
months later in 30%. Mathew et al (12) investigated in a
prospective, randomized double-blinded, placebo con-
trolled study whether a continuous infusion of lidocaine
(bolus 1mg/kg followed by 1mg/min for the next 48h)
would reduce postoperative cognitive dysfunction after
cardiac surgery using cardiopulmonary bypass. This work
demonstrated that lidocaine did not reduce the incidence
of cognitive dysfunction, but in non-diabetic patients a
secondary analysis did show a protective effect, which
was still present 1 year after surgery. This study suggests
that certain patients, but not all, may benefit from this
treatment.
Neuropathic pain is a chronic condition characteriz-
ed by spontaneous pain, allodynia, hyperalgesia, and
sensory deficits in the painful area. Treatment is still
often inadequate. Gormen et al (13) were able to show
that both AMPA/GluR5 antagonist (NS 1209) and lido-
caine reduced significantly brush – evoked allodynia and
cold allodynia in a small group of patients with well-
-defined neuropathic pain symptoms. These are key ele-
ments of neuropathic pain suggesting that AMPA recep-
tor ligands may be involved in pain modulation and also
that lidocaine may interfere with this receptor. In order to
elucidate the question whether lidocaine analgesic ef-
fects are mediated through central rather than peripheral
nervous system action, Luo et al (14) performed fMRI in
anesthetized rats to quantify brain activation patterns in
response to innocuous and noxious forepaw stimulation
before and after i.v. administration of lidocaine. The
authors found in this animal model that lidocaine when
administered intravenously, did not abolish or diminish
the brain’s response as measured by functional magnetic
resonance imaging using the blood-oxygen-level depen-
dent activation to innocuous or acute noxious electrical
stimulation of the forepaw in normal rats. Moreover, this
investigation showed that lidocaine enhanced the soma-
tosensory cortical response to acute noxious stimulation.
This is in contrast to what has been observed previously
for opioid analgesics (15). These findings raised several
challenging questions regarding the mode of action of
lidocaine in the setting of neuropathic pain. The efficacy
of lidocaine application to relieve neuropathic pain was
further confirmed by Kanai et al (16). They compared
the metered-dose 8% lidocaine pump spray to saline
placebo pump in patients having posttraumatic peri-
pheral neuropathy. The pump sprays were applied di-
rectly to painful skin areas. The results demonstrated
that the lidocaine pump spray, but not the placebo one,
significantly decreased the intensity of the continuing pain
and tactile allodynia. Compared to patch this system has
the advantages to have a more rapid onset of action and
the possibility to increase the dose when necessary.
There is growing evidence that local anesthetics mo-
dulate a wide range of ion channels other than sodium
channels. How systemic application of lidocaine exerts
its analgesic effect is not entirely clear. In order to better
document this effect Muth-Selbach et al (17) administer-
ed intrathecally on rats l-serine (an agonist at the gly-
cine-binding site at the NMDA receptor), its inactive
isomer I-serine CGP 78608 (antagonist at the glycineB-
-site of the NMDA receptor) and strychnine (antagonist
at inhibitory glycine receptor) after the animals received
i.v. lidocaine and formalin s.c. in the paw. The results
indicated a modulatory effect of lidocaine on the NMDA
receptor and since lidocaine-induced antinociception was
antagonized by both glycineB-site modulators and strych-
nine, this would favour the hypothesis of a general gly-
cine-like action on inhibitory strychnine-sensitive recep-
tors and on strychnine-insensitive glycine receptors. This
is one new possible mechanism to explain lidocaine ef-
fect. However, chronic / neuropatic pain is such a com-
plex process that research is still needed to have a better
understanding.
MDMA (3.4 methylene-dioxy-methamphetamine) is
commonly consumed by many teenagers and young adults.
MDMA is more and more frequently consumed with a
local anesthetic, cocaine. The influence of this "cocktail"
on motor activity, anxiety, memory and brain mono-
amines in adolescent mice has been assessed18. This
investigation showed that both drugs, administered alone
or concurrently, produced hyperactivity and decrease in
social contacts. However, an anxiolytic effect assessed by
means of elevated plus maze and expressed as an increase
in the time on the open arms, was observed only in those
animals treated with both MDMA and cocaine. Mice
treated with MDMA did not present significant changes
in brain monoamines, while those receiving both drugs
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showed a decrease in dopamine in the striatum, which
was accompanied by an increase in the serotonin con-
centration in the striatum and cortex 30min after ad-
ministration. It is known that acute activation of neurons
by cocaine induces long-term changes in behaviour by
activating transcriptional complexes and that young ado-
lescent male rats have greater locomotor responses than
adults after acute low dose cocaine administration.
The purpose of Caster’s investigation (19) was to
correlate cocaine-induced locomotor activity with neu-
ronal activation in different regions in the brain by acute
cocaine in young adolescents and adult rats by mea-
suring the induction of the plasticity-associated imme-
diate early genes c-fos and zif268. It was found that low
dose cocaine induced more locomotor activity and stria-
tal c-fos expression in adolescents than adults whereas
high dose cocaine induced more locomotor activity, striatal
c-fos and striatal zif268 expression in adults. Locomotor
activity correlated with the expression of both genes in
adults but correlated with striatal c-fos only in adoles-
cents. There was also a significant correlation between
the expression of c-fos and zif 268 in the adult striatum
but not in adolescents. These interesting results suggest
that the coordinated expression of transcription factors
by cocaine continues to develop during adolescence. The
immature regulation of transcription factors by cocaine
could explain why adolescents show unique sensitivity to
specific long-term behavioural alterations following co-
caine treatment.
Intrathecal administration
Local anesthetics are frequently administered intra-
thecally for various procedures or pathologies. Tian et al
(20) investigated the best dosage of lidocaine administer-
ed intrathecally in a rat model of established thermal
hyperalgesia and tactile allodynia. The following dosages
were compared: 2, 6.5, 15 and 35mg/kg. Behavioural tests
indicated that 6.5, 15 and 35mg/kg showed different de-
grees of reversal of thermal hyperalgesia lasting 2–8 days,
while 2mg/kg did not. The inhibition of tactile allodynia
was only observed in rats receiving 15 and 35mg/kg.
Considering the ratio benefits/side-effects, the dosage of
15 mg/kg was the most suitable for this indication. How-
ever, the mechanisms of action remain to be elucidated.
Ambulatory surgical procedures are more and more
commonly used worldwide. Spinal anesthesia is a good
and reliable technique in this setting. However, lido-
caine, which has been frequently used in this indication,
has been reported to be neurotoxic. In order to look for
more suitable alternative Takenami et al (21) compared
the clinical course and toxicity of different local anesthetics
administered intrathecally in rats. Different concentra-
tions of prilocaine, mepivacaine, procaine or bupivacaine
were compared. Among the 4 local anesthetics tested,
procaine has the mildest neurotoxicity and the fastest
recovery time to ambulation.
Lidocaine has been implicated in the occurrence of
TNS (22). However, the exact mechanism explaining
TNS is still unknown. In order to have a better under-
standing of the possible neurotoxicity of lidocaine, freely
moving rats received either saline, 400 or 1000ug of lido-
caine intrathecally (23). The impact of a pre-treatment
with an NMDA glutamate antagonist and a COX2 inhi-
bitor was also assessed. Cerebrospinal PGE2 levels in-
creased to 400% of baseline and remained elevated for
90–120min after intrathecal lidocaine at both doses. Pre-
treatment with both inhibitors attenuated this increase.
A 40 min period of enhanced pain after von Frey filament
stimulation – temporary state of spinal cord sensitization
– was observed during and after sensory and motor block
recovery. This work showed that intrathecal lidocaine
provokes a transient period of hyperalgesia. Yet, the link
with the PGE2 increase and the occurrence of hyper-
algesia (TNS?) needs to be further investigated.
Despite adequate needle placement, application of
the right local anesthetic at the adequate concentration,
2–3 % of spinals still fail. Steiner et al (24) assessed
bupivacaine cerebrospinal fluid (CSF) concentration in
all patients with inadequate block, after intrathecal ap-
plication of bupivacaine 0,5%. In this investigation 2600
spinals were considered. The failure rate was 2.7%. A
CSF concentration of bupivacaine of 73ug ml–1 was con-
sidered adequate for a successful spinal. In the failure
group the CSF concentration was between 3.36 and 1020
ug.ml–1. A large number of failures had a concentration
below 73ug.ml–1, but some of them were above, suggest-
ing maldistribution of local anesthetic to explain the
failure. This work highlights the fact that inadequate
CSF local anesthetic concentration may explain some
cases, but not all, of spinal failure in the absence of
technical problem. Other issue like drug maldistribution
should be considered.
Antimicrobial properties
Local anesthetics have long been known to inhibit the
growth of different species in vitro (25). Infiltration of
surgical wound with 2ml lidocaine 2% prior to inocu-
lation was associated with an average decrease in bacte-
rial count of >70%26. Epidural abscess is an uncommon
yet serious complication of epidural catheterisation. Cogh-
lan et al (27) investigated the antibacterial activity of
various local anesthetics and additives used in epidural
infusions, against a range of micro-organisms associated
with epidural abscess. Different concentrations of bupi-
vacaine, ropivacaine and levobupivacaine with or with-
out fentanyl, adrenaline or clonidine were tested. Bupi-
vacaine was shown to have the most efficient activity
against micro-organisms. It showed antibacterial activity
against staphylococcus aureus, enterococcus faecalis and
escherichia coli with minimum inhibitory concentra-
tions between 0.125% and 0.25%. However, bupivacaine
did not inhibit the growth of pseudomonas aeruginosa.
Levobupivacaine and ropivacaine had no activity against
any of the micro organisms tested. The presence of fent-
anyl, adrenaline and clonidine had no additional effect
on the antimicrobial activity of any of the local anesthetic
tested. While the clinical implications of this in vitro
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study are not known, consideration should be given to
use higher concentration of LA (bupivacaine 0.25% has a
greater antimicrobial activity than 0.125%) in epidural
infusion in order to take advantage of this property.
The application of EMLA® cream is indicated for
topical anesthesia of the skin in connection with i.v.
cannulation, as vascular access is often linked with noso-
comial infection. The impact of EMLA® cream (an eu-
tectic mixture of lidocaine 2.5% and prilocaine 2.5%) on
the skin flora was investigated by Batai et al (28). They
compared the bacteriostatic / bactericidal effect of EMLA®
with Skinsept Pur® (alcohol based disinfectant) disinfec-
tion. Samples were taken from 0 to 12h after treatment.
EMLA® cream was shown to have a similar bactericidal
effect than Skinsept Pur® and a longer bacteriostatic
effect. This difference was significant after 4h. Whether
this finding may have clinical relevance in terms of re-
ducing nosocomial infection need further studies.
Cancer recurrence
Surgery still remains a cornerstone in the manage-
ment of cancer patients. However, surgery inevitably
induces a profound neuroendocrine, metabolic, and cy-
tokine response. A retrospective analysis has suggested
that paravertebral anesthesia and analgesia for breast
cancer surgery reduced the risk of recurrence of meta-
stasis during the initial years of follow-up (29). Biki et al
(30) performed a similar retrospective review of cancer
patients after radical prostatectomy. They compared out-
come between a group having general anesthesia with
either opioid analgesia or epidural analgesia. This analy-
sis showed that open prostatectomy surgery with general
anesthesia, substituting epidural analgesia for postopera-
tive opioids, was associated with substantially less risk of
biochemical cancer recurrence. These exciting perspecti-
ves warrant prospective, randomized trials to evaluate
this association. General anesthesia, pain, sympathetic
blockade, all are involved in the modulation of the im-
mune system. The natural killer cells (NK) are an im-
portant part of non-specific cellular-mediated and anti-
tumoral immunity. Forget and De Kock (31) performed a
systematic review to recapitulate data over NK activity
during the perioperative period and the influence of
anesthesia, analgesia and modulation of sympathetic sys-
tem. It came out from this review that local anesthetics,
contrary to opioids, stimulate the activity of NK cells
during the perioperative period. However, it is important
to keep in mind that the long term consequences of each
technique on patient’s outcome warrant further investi-
gations. Yardeni et al (32) assessed pain intensity and
immune reactivity in two groups of female patients sche-
duled for transabdominal surgery assigned either to i.v.
lidocaine started 20min before surgery or a placebo. All
patients had patient-controlled epidural analgesia. In the
lidocaine group postoperative pain at rest and during
coughing was less in the first 8 postoperative hours. The
in vivo production of IL-1ra and IL-6 was significantly
reduced, whereas the lymphocyte proliferation response
to phytohemmaglutinin-M was better maintained in the
control group. This study indicates that i.v. lidocaine
reduces surgery-induced immune alterations. The long-
-term clinical implications of these findings are unknown
and warrant future investigations.
CONCLUSIONS
It is fascinating that more than decades after the intro-
duction of local anesthetics for perioperative analgesia,
we may still discover new properties and anticipate new
applications of this class of drugs. Various types of in-
flammation including neuroprotection, acute lung inju-
ry, bowel function recovery and maybe cancer recurrence
may be positively influenced by the application of local
anesthetics. These issues are without any doubt the chal-
lenges of the coming years.
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